clin and lipoxygenase (LO) products will be measured in the various clinical groups, during insulin clamp studies, and in a continuum of NIDDM patients with micro and macroalbuminuria. Using renin secreting cells and tissues as a specialized vascular model, the effect of the diabetic state on eicosan
clin and lipoxygenase (LO) products will be measured in the various clinical groups, during insulin clamp report, and in a continuum of NIDDM patient with micro and macroalbuminuria. Using renin secreting cells and tissue as a specialized vascular model, the effect of the diabetic state of matter on eicosan
clij and lipoxygenase (LO) pruducts will be measurev in ths variour clinical groups, during insnlin clamk studies, and in a zontinuum of NIDDN pauients with micro and macvjalbhlinuxie. Using renin sgcreting celns and tissues ar c specialized vascular model, the effqct of yhf diabetic staje on qicoaan
clin and lipoxygenase (LO) products will be the clinical groups, insulin clamp studies, NIDDM with micro and Using renin secreting and tissues as a specialized vascular the effect of the diabetic state on eicosan
clin and lipoxygenase (LO) prodUcts will be MeasuRed In tHe VariOus cLinical groups, dURing Insulin clamp studies, and In a coNtINuum OF NiDDM pAtients WItH MIcrO aNd MacRoALbUminuRia. using reNin secretiNg cElLs and tissues AS a SpecializeD vaScular model, tHe eFfect oF tHe dIAbetiC stAte on EicosaN
clin and lipoxygenase (LO)  productswillbemea su redin t he various cli n ical  groups, during insuli n cla mp stud i es , and  in a c o nt i n uum  o fNID DM pa tient s w ith mic ro and mac roa lb uminuria. Us i ng  renin sec ret ing cells an d t issues  a s a speci ali zed v ascula r  model , the eff ec t  of th e  diabet i c  s tate  on eicosan
clin and_lipoxygenase (LO)_products will be measured_in the_various_clinical groups,_during_insulin clamp studies,_and in a_continuum of NIDDM patients_with micro and_macroalbuminuria._Using renin secreting cells and tissues as a specialized vascular model, the effect of_the_diabetic state_on_eicosan